Aihong H. Guo

Xianyang, 712000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Ensemble machine learning algorithms leveraged on serum proteomics for enhanced early detection of ovarian cancer.

Ensemble machine learning algorithms leveraged on serum proteomics for enhanced early detection of ovarian cancer.

Journal: Scientific reports

Published: December 02, 2025

MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome.

MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome.

Journal: Cell death & disease

Published: November 06, 2025

Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China.

Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China.

Journal: Cephalalgia : an international journal of headache

Published: October 09, 2025

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: May 08, 2025

Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer from Mass Spectrometry-Based Proteomics Data.

Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer from Mass Spectrometry-Based Proteomics Data.

Journal: Bioengineering (Basel, Switzerland)

Published: February 06, 2025

Lepalvir: Biomaterial efficacy and safety for patients with acute ischemic stroke.

Lepalvir: Biomaterial efficacy and safety for patients with acute ischemic stroke.

Journal: iScience

Published: October 15, 2024

Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Journal: The journal of headache and pain

Published: December 12, 2023

Serum proteomic analysis uncovers novel serum biomarkers for depression.

Serum proteomic analysis uncovers novel serum biomarkers for depression.

Journal: Frontiers in psychiatry

Published: November 29, 2023

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial.

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Neurology

Published: January 05, 2023

An assessment of the correlation between early postinfarction pyramidal tract Wallerian degeneration and nerve function recovery using diffusion tensor imaging.

An assessment of the correlation between early postinfarction pyramidal tract Wallerian degeneration and nerve function recovery using diffusion tensor imaging.

Journal: Genetics and molecular research : GMR

Published: January 28, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026